Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atezolizumab and Bevacizumab in Hepatocellular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05173298
What this trial is testing

Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

Who this might be right for
Advanced Hepatocellular Carcinoma
CHA University 100
Not applicableNot Yet RecruitingNCT07734857
What this trial is testing

Peripheral Blood Biomarkers and Response to Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai Zhongshan Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06535737
What this trial is testing

A Phase 2, Single Arm Study of Cabozantinib in Patients With Hepatocellular Carcinoma Who Have Received Prior Atezolizumab and Bevacizumab

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Chulalongkorn University 40
Not applicableUnknownNCT06244446
What this trial is testing

Efficacy and Safety of SBRT Combined With Atezolizumab Plus Bevacizumab vs Atezolizumab Plus Bevacizumab in Treating Unresectable Advance Hepatocellular Carcinoma.

Who this might be right for
Advanced Hepatocellular Carcinoma
Institute of Liver and Biliary Sciences, India 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06984718
What this trial is testing

A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC

Who this might be right for
HCCHepatocellular Carcinoma
Akeso 120
Testing effectiveness (Phase 2)UnknownNCT05134532
What this trial is testing

Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
CHA University 40
Testing effectiveness (Phase 2)Looking for participantsNCT07018947
What this trial is testing

Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC

Who this might be right for
Resectable Hepatocellular Carcinoma
Fundacion Clinic per a la Recerca Biomédica 90
Not applicableLooking for participantsNCT07495735
What this trial is testing

Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular CarcinomaAtezolizumab and Bevacizumab in Hepatocellular Carcinoma
First Affiliated Hospital of Wenzhou Medical University 400
Large-scale testing (Phase 3)Not Yet RecruitingNCT06680258
What this trial is testing

TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Tempest Therapeutics 740
Testing effectiveness (Phase 2)Active Not RecruitingNCT04727307
What this trial is testing

Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Montpellier 202
Large-scale testing (Phase 3)Looking for participantsNCT04803994
What this trial is testing

The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 434
Testing effectiveness (Phase 2)Ended earlyNCT05137899
What this trial is testing

Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumour Thrombosis
Ontario Clinical Oncology Group (OCOG) 1
Large-scale testing (Phase 3)Study completedNCT04102098
What this trial is testing

Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 668
Post-approval studies (Phase 4)Looking for participantsNCT07059494
What this trial is testing

Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant

Who this might be right for
Hepatocellular Carcinoma
Icahn School of Medicine at Mount Sinai 40
Testing effectiveness (Phase 2)Study completedNCT05101629
What this trial is testing

Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy

Who this might be right for
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 32
Testing effectiveness (Phase 2)Ended earlyNCT05776875
What this trial is testing

Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC

Who this might be right for
Hepatocellular CarcinomaBCLC Stage B Hepatocellular Carcinoma
Yale University 3
Testing effectiveness (Phase 2)Looking for participantsNCT07239245
What this trial is testing

Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo

Who this might be right for
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)WithdrawnNCT06006286
What this trial is testing

A Study Evaluating Atezolizumab and Bevacizumab Plus ADI-PEG 20 in Patients With Locally Advanced / Metastatic Hepatocellular Carcinoma

Who this might be right for
Metastatic Hepatocellular Carcinoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06605664
What this trial is testing

Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab

Who this might be right for
Hepatocellular Carcinoma (HCC)
Chang Gung Memorial Hospital 45
Not applicableActive Not RecruitingNCT07669597
What this trial is testing

Comparison of Atezolizumab/Bevacizumab Versus Durvalumab/Tremelimumab (STRIDE) Protocols in Locally Advanced or Metastatic Hepatocellular Carcinoma Among Patients in Sohag

Who this might be right for
Locally Advanced or Metastatic Hepatoceullar Carcinoma
Sohag Oncology Center 50
Next Page